Insiders Trades

★ Sign in to follow

JM

James Mellon

Shareholder

Portage Biotech Inc.

Cumul. flow

Total declarations

19

Company

1

▲ Purchases (8 ops.)

€67k

▼ Sales (0 ops.)

—

Latest filing published 03 Mar 2021 for Portage Biotech Inc..

Insider track record

Disclosed buys

8

Disclosed sells

0

Signal history

James Mellon: trading record in brief

All filings by James Mellon on record concern Portage Biotech Inc. In total, 19 filings cover trades dated from 4 June 2013 to 3 March 2021.

Every open-market trade on record is a purchase: 8 purchases worth €67k, and no sale. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Besides market trades, the filings include 2 share grants and 2 option exercises.

The median purchase comes to €5,077. Across 8 purchases, this insider has always bought alone, with no colleague buying within 30 days.

The latest filing, published on 3 March 2021, reports a transaction in Portage Biotech Inc. The last insider purchase was made public on 2 September 2016, 3,707 days ago. Between a trade and the moment it shows up on SEDI, the median delay is 4 days. The shorter that gap, the sooner other investors can see what insiders have done. This summary is built from SEDI disclosures alone and does not predict where the share price will go.

Companies and markets linked to James Mellon

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Portage Biotech Inc. (CA)

Declarations19 total

●

3 - 10% Security Holder of Issuer, 4 - Director of IssuerExecutives3 Mar 2021Portage Biotech Inc.

0SEDI

117,193 sharesCommon SharesTSXSEDI:3692070

●

3 - 10% Security Holder of Issuer, 4 - Director of IssuerExecutives12 Jun 2020Portage Biotech Inc.

1M CAD14SEDI

100,000 shares@ CA$10.0027.1% of flowCommon SharesTSXSEDI:3563811

●

3 - 10% Security Holder of Issuer, 4 - Director of IssuerExecutives4 Jun 2013Portage Biotech Inc.

0SEDI

Common SharesTSXSEDI:3563809

●

3 - 10% Security Holder of Issuer, 4 - Director of IssuerExecutives5 Jun 2020Portage Biotech Inc.

0SEDI

3,096,875 sharesCommon SharesTSXSEDI:3563150

●

3 - 10% Security Holder of Issuer, 4 - Director of IssuerExecutives5 Jun 2020Portage Biotech Inc.

0SEDI

309,687,540 sharesCommon SharesTSXSEDI:3563149

●

3 - 10% Security Holder of Issuer, 4 - Director of IssuerExecutives9 Jan 2019Portage Biotech Inc.

2M CAD19SEDI

23,563,141 shares@ CA$0.08986.9% of flowCommon SharesTSXSEDI:3301329

◆

3 - 10% Security Holder of Issuer, 4 - Director of IssuerExecutives2 Jan 2018Portage Biotech Inc.

0SEDI

165,000 sharesCommon SharesTSXSEDI:3113208

◇

3 - 10% Security Holder of Issuer, 4 - Director of IssuerExecutives2 Jan 2018Portage Biotech Inc.

6,251 CAD11SEDI

41,674 shares@ CA$0.150.3% of flowCommon SharesTSXSEDI:3113210

◇

3 - 10% Security Holder of Issuer, 4 - Director of IssuerExecutives27 Nov 2017Portage Biotech Inc.

188,749 CAD12SEDI

1,258,326 shares@ CA$0.155.2% of flowCommon SharesTSXSEDI:3089031

◆

3 - 10% Security Holder of Issuer, 4 - Director of IssuerExecutives23 Mar 2017Portage Biotech Inc.

0SEDI

650,000 sharesCommon SharesTSXSEDI:2983561

▲

3 - 10% Security Holder of Issuer, 4 - Director of IssuerExecutives30 Aug 2016Portage Biotech Inc.

14,660 CAD17SEDI

117,000 shares@ CA$0.12530.6% of flowCommon SharesTSXSEDI:2885260

Canonical exit: 28 Nov 2016 (T+90)

▲

3 - 10% Security Holder of Issuer, 4 - Director of IssuerExecutives2 Aug 2016Portage Biotech Inc.

33,580 CAD13SEDI

268,000 shares@ CA$0.12531.4% of flowCommon SharesTSXSEDI:2885257

Canonical exit: 31 Oct 2016 (T+90)

▲

3 - 10% Security Holder of Issuer, 4 - Director of IssuerExecutives12 Aug 2016Portage Biotech Inc.

1,880 CAD15SEDI

15,000 shares@ CA$0.12530.1% of flowCommon SharesTSXSEDI:2885259

Canonical exit: 10 Nov 2016 (T+90)

●

3 - 10% Security Holder of Issuer, 4 - Director of IssuerExecutives31 Mar 2016Portage Biotech Inc.

250,000 CAD12SEDI

1,666,667 shares@ CA$0.1510.6% of flowCommon SharesTSXSEDI:2819995

▲

3 - 10% Security Holder of Issuer, 4 - Director of IssuerExecutives3 Feb 2016Portage Biotech Inc.

5,380 CAD17SEDI

53,800 shares@ CA$0.100.2% of flowCommon SharesTSXSEDI:2783396

Canonical exit: 3 May 2016 (T+90)

▲

3 - 10% Security Holder of Issuer, 4 - Director of IssuerExecutives28 Jan 2016Portage Biotech Inc.

6,993 CAD15SEDI

70,000 shares@ CA$0.09990.3% of flowCommon SharesTSXSEDI:2779846

Canonical exit: 27 Apr 2016 (T+90)

▲

3 - 10% Security Holder of Issuer, 4 - Director of IssuerExecutives29 Jan 2016Portage Biotech Inc.

28,369 CAD17SEDI

285,400 shares@ CA$0.09941.1% of flowCommon SharesTSXSEDI:2779857

Canonical exit: 28 Apr 2016 (T+90)

▲

3 - 10% Security Holder of Issuer, 4 - Director of IssuerExecutives27 Jan 2016Portage Biotech Inc.

8,600 CAD13SEDI

86,000 shares@ CA$0.100.3% of flowCommon SharesTSXSEDI:2778655

Canonical exit: 26 Apr 2016 (T+90)

▲

3 - 10% Security Holder of Issuer, 4 - Director of IssuerExecutives26 Jan 2016Portage Biotech Inc.

408 CAD11SEDI

4,800 shares@ CA$0.0850.0% of flowCommon SharesTSXSEDI:2778327

Canonical exit: 25 Apr 2016 (T+90)

19 of 19 declarations